Ziopharm Oncology Inc – ‘10-Q’ for 6/30/17 – ‘EX-101.CAL’

On:  Monday, 7/31/17, at 4:02pm ET   ·   For:  6/30/17   ·   Accession #:  1193125-17-242331   ·   File #:  1-33038

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    615K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
11: R1          Document and Entity Information                     HTML     38K 
12: R2          Balance Sheets                                      HTML     98K 
13: R3          Balance Sheets (Parenthetical)                      HTML     47K 
14: R4          Statements of Operations                            HTML     48K 
15: R5          Statements of Stockholders' Deficit                 HTML     60K 
16: R6          Statements of Stockholders' Deficit                 HTML     18K 
                (Parenthetical)                                                  
17: R7          Statements of Cash Flows                            HTML     97K 
18: R8          Statements of Cash Flows (Parenthetical)            HTML     18K 
19: R9          Business                                            HTML     30K 
20: R10         Financings                                          HTML     20K 
21: R11         Summary of Significant Accounting Policies          HTML     27K 
22: R12         Fair Value Measurements                             HTML     45K 
23: R13         Net Loss per Share                                  HTML     28K 
24: R14         Commitments and Contingencies                       HTML    104K 
25: R15         Related Party Transactions                          HTML     36K 
26: R16         Stock-Based Compensation                            HTML     56K 
27: R17         Preferred Stock                                     HTML     34K 
28: R18         Derivative Financial Instruments                    HTML     35K 
29: R19         Summary of Significant Accounting Policies          HTML     27K 
                (Policies)                                                       
30: R20         Fair Value Measurements (Tables)                    HTML     36K 
31: R21         Net Loss per Share (Tables)                         HTML     25K 
32: R22         Stock-Based Compensation (Tables)                   HTML     58K 
33: R23         Derivative Financial Instruments (Tables)           HTML     36K 
34: R24         Business - Additional Information (Detail)          HTML     21K 
35: R25         Financings - Additional Information (Detail)        HTML     25K 
36: R26         Assets and Liabilities Measured at Fair Value on    HTML     31K 
                Recurring Basis (Detail)                                         
37: R27         Fair Value Measurements - Additional Information    HTML     22K 
                (Detail)                                                         
38: R28         Potential Dilutive Shares Excluded from             HTML     28K 
                Computation of Diluted Net Loss Per Share (Detail)               
39: R29         Net Loss per Share - Additional Information         HTML     26K 
                (Detail)                                                         
40: R30         Commitments and Contingencies - Additional          HTML    303K 
                Information (Detail)                                             
41: R31         Related Party Transactions - Additional             HTML    115K 
                Information (Detail)                                             
42: R32         Stock-Based Compensation Expense Included in        HTML     25K 
                Statement of Operations (Detail)                                 
43: R33         Stock-Based Compensation - Additional Information   HTML     40K 
                (Detail)                                                         
44: R34         Fair Value of Stock Options Assumptions Using       HTML     32K 
                Black-Scholes Option Valuation Model (Detail)                    
45: R35         Stock Option Activity Under Stock Option Plan       HTML     62K 
                (Detail)                                                         
46: R36         Summary of Unvested Restricted Stock (Detail)       HTML     42K 
47: R37         Preferred Stock - Additional Information (Detail)   HTML     54K 
48: R38         Fair Values of Derivative Instruments to be         HTML     23K 
                classified as Derivative Liabilities on Balance                  
                Sheet (Detail)                                                   
49: R39         Change in Derivative Liability (Detail)             HTML     25K 
50: R40         Fair Value Assumptions Used in Probability          HTML     29K 
                Weighted Approach and Monte Carlo Simulation Model               
                (Detail)                                                         
52: XML         IDEA XML File -- Filing Summary                      XML     90K 
51: EXCEL       IDEA Workbook of Financial Reports                  XLSX     55K 
 5: EX-101.INS  XBRL Instance -- ziop-20170630                       XML    764K 
 7: EX-101.CAL  XBRL Calculations -- ziop-20170630_cal               XML    109K 
 8: EX-101.DEF  XBRL Definitions -- ziop-20170630_def                XML    487K 
 9: EX-101.LAB  XBRL Labels -- ziop-20170630_lab                     XML    902K 
10: EX-101.PRE  XBRL Presentations -- ziop-20170630_pre              XML    643K 
 6: EX-101.SCH  XBRL Schema -- ziop-20170630                         XSD    126K 
53: ZIP         XBRL Zipped Folder -- 0001193125-17-242331-xbrl      Zip    110K 

‘EX-101.CAL’   —   XBRL Calculations — ziop-20170630_cal

This Exhibit is an XBRL XML File.